Diabetes mellitus
type 2 group I
Atherosclerosis
group II
control group significance
A B C D
Creatinine [mg/dl] 1.1 ± 0.3 1.0 ± 0.2 1.1 ± 0.2 1.2 ± 0.4 0.9 ± 0.1 A vs. C; NS
B vs. D; NS
A vs. contr.; p<0.001
B vs. contr.; NS
C vs. contr.; p<0.005
D vs. contr.; p<0.05
uric acid [mg/dl] 5.1 ± 1.3 4.2 ± 1.0 5.2 ± 1.2 4.5 ± 1.2 4.0 ± 1.4 A vs. C; NS
B vs. D; NS
A vs. contr.; p<0.001
B vs. contr.; NS
C vs. contr.; p<0.01
D vs. contr.; NS
total cholesterol [mg/dl] 217.4 ± 49.0 180.3 ± 49.0 229.4 ± 43.3 205.2 ± 47.2 189.4 ± 25.4 A vs. C; NS
B vs. D; NS
A vs. contr.; p<0.05
B vs. contr.; NS
C vs. contr.; p<0.001
D vs. contr.; NS
LDL cholesterol [mg%] 118.8 ± 43.5 85.9 ± 31.8 148.1 ± 43.8 119.6 ± 41.7 102.8 ± 25.3 A vs. C; p<0.01
B vs. D; p<0.05
A vs. contr.; NS
B vs. contr.; NS
C vs. contr.; p<0.001
D vs. contr.; NS
HDL cholesterol [mg/dl] 48.4 ± 12.3 46.1 ± 11.7 46.4 ± 11.7 54.2 ± 17.2 67.2 ± 14.1 A vs. C; NS
B vs. D; NS
A vs. contr.; p<0.001
B vs. contr.; p<0.001
C vs. contr.; p<0.001
D vs. contr.; p<0.01
triglycerides [mg/dl] 293.1 ± 235.5 217.5 ± 20.4 173.1 ± 74.1 167.8 ± 91.4 97.2 ± 39.3 A vs. C; p<0.01
B vs. D; NS
A vs. contr.; p<0.001
B vs. contr.; p<0.001
C vs. contr.; p<0.001
D vs. contr.; p<0.01
Results are expressed as mean ± standard deviation. NS: Not Statistically Significant
Table 2: Selected laboratory parameters of the analyzed groups.